Image may be NSFW.
Clik here to view.
Shares in Catalent (NYSE:CTLT) jumped more than 20% last week after the company beat expectations on Wall Street with its fiscal 3rd quarter results.
The Somersert, N.J.-based company posted profits of $26 million, or 21¢ per share, on sales of $532.6 million for the 3 months ended March 31, for bottom-line growth of 143% on sales growth of 22% compared with the same period last year.
Get the full story at our sister site, Drug Delivery Business News.
The post Catalent soars on Q3 earnings, sales beat appeared first on MassDevice.
